SlideShare a Scribd company logo
1 of 14
ASSIGNMENT ON DRUG DATABASE
PREPARED BY :
MUSTAFA KAMAL AHMED KHAN
ENROLMENT NO.: 2018-340-006
B.Sc (Toxicology) - 5TH SEMESTER
DEPARTMENT OF TOXICOLOGY
JAMIA HAMDARD, NEW DELHI
Submitted to-
Dr. Nidhi C. Dubey
Dated : 26-11-2020
DRUG DATABASE
Drug databases are sites where information about drugs and medications are stored, and one of the
largest (and most commonly used) drug databases is compiled by the Food & Drug Administration
(FDA).
The FDA is a federal agency that oversees and controls all medications in the U.S., which includes:
 Over-the-counter (OTC) medications
 Prescription medications
 Dietary supplements
 Vaccines
• The FDA drug database includes most of the drugs they have approved in the U.S.
since 1939. Best of all, this database is extremely easy to use. To search this database,
you simply need to go to the FDA drug database's website. Once you get to this
website, you are able to search the database by typing in the name of the drug or by
typing in any active ingredient of a drug.
• Additionally, the FDA drug database can be used to search drugs that are currently
going through clinical trials and/or the approval process. The FDA must approve a drug
before it is legally able to be sold and used in the United States. Therefore, drug
companies must formally submit an application to the FDA for the drug to be
approved. The drugs that have been submitted to the FDA but not yet approved can
be found in this database.
Screenshot of homepage of Drugs@FDA
Website: https://www.accessdata.fda.gov/scripts/cder/daf/
The Pubchem
PubChem is a database of chemical molecules and their activities against biological assays. The system is
maintained by the National Centre for Biotechnology Information (NCBI), a component of the National Library of
Medicine, which is part of the United States National Institutes of Health (NIH). PubChem can be accessed for free
through a web user interface. Millions of compound structures and descriptive datasets can be freely downloaded
via FTP. PubChem contains substance descriptions and small molecules with fewer than 1000 atoms and 1000
bonds. More than 80 database vendors contribute to the growing PubChem database.
Databases
PubChem consists of three dynamically growing primary databases. As of 1 November 2017:
 Compounds, 93.9 million entries (up from 54 million entries in Sept 2014), contains pure and characterized
chemical compounds.
 Substances, 236 million entries (up from 163 million entries in Sept 2014), contains also
mixtures, extracts, complexes and uncharacterized substances.
 Bio-Assay, bioactivity results from 1.25 million (up from 6000 in Sept 2014) high-throughput
screening programs with several million values.
Searching the databases is possible for a broad range of properties including chemical structure, name
fragments, chemical formula, molecular weight, LogP, and hydrogen bond, donor and acceptor count., etc.
PubChem contains its own online molecule editor with SMILES/SMARTS and InChI support that allows the
import and export of all common chemical file formats to search for structures and fragments.
Each hit provides information about synonyms, chemical properties, chemical structure including SMILES and
InChI strings, bioactivity, and links to structurally related compounds and other NCBI databases like PubMed.
In the text search form the database fields can be searched by adding the field name in square brackets to the
search term. A numeric range is represented by two numbers separated by a colon. The search terms and field
names are case-insensitive. Parentheses and the logical operators AND, OR, and NOT can be used. AND is
assumed if no operator is used.
Contd…
Website : https://pubchem.ncbi.nlm.nih.gov/
Screenshot of homepage of pubchem website
Contd…
PubMed is a free search engine accessing primarily the MEDLINE database of references and abstracts on life sciences and
biomedical topics. The United States National Library of Medicine (NLM) at the National Institutes of Health maintain the
database as part of the Entrez system of information retrieval.
From 1971 to 1997, online access to the MEDLINE database had been primarily through institutional facilities, such
as university libraries. PubMed, first released in January 1996, ushered in the era of private, free, home- and office-based
MEDLINE searching. The PubMed system was offered free to the public starting in June 1997.
In addition to MEDLINE, PubMed provides access to:
 older references from the print version of Index Medicus, back to 1951 and earlier
 references to some journals before they were indexed in Index Medicus and MEDLINE, for instance Science, BMJ,
and Annals of Surgery
 very recent entries to records for an article before it is indexed with Medical Subject Headings (MeSH) and added to
MEDLINE
 a collection of books available full-text and other subsets of NLM records
 PMC citations
 NCBI Bookshelf
The Pubmed
Website: https://pubmed.ncbi.nlm.nih.gov/
Screenshot of homepage of pubmed website
Contd…
The DrugBank database is a comprehensive, freely accessible, online database containing information
on drugs and drug targets. As both a bioinformatics and a cheminformatics resource, DrugBank combines detailed
drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence,
structure, and pathway) information. DrugBank has used content from Wikipedia; Wikipedia also often links to
Drugbank, posing potential circular reporting issues.
The latest release of the database (version 5.0) contains 9591 drug entries including 2037 FDA-approved small
molecule drugs, 241 FDA-approved biotech (protein/peptide) drugs, 96 nutraceuticals and over 6000 experimental
drugs. Additionally, 4270 non-redundant protein (i.e. drug target/enzyme/transporter/carrier) sequences are linked
to these drug entries. Each DrugCard entry contains more than 200 data fields with half of the information being
devoted to drug/chemical data and the other half devoted to drug target or protein data.
Four additional databases, HMDB, T3DB, SMPDB and FooDB are also part of a general suite
of metabolomic/cheminformatic databases. HMDB contains equivalent information on more than 40,000 human
metabolites, T3DB contains information on 3100 common toxins and environmental pollutants, SMPDB contains
pathway diagrams for nearly 700 human metabolic pathways and disease pathways, while FooDB contains
equivalent information on ~28,000 food components and food additives.
The DrugBank
All data in DrugBank is non-proprietary or is derived from a non-proprietary source. It is freely accessible and available to anyone.
In addition, nearly every data item is fully traceable and explicitly referenced to the original source. DrugBank data is available
through a public web interface and downloads.
Users may query DrugBank in a number of ways:
 Simple text queries of the entire textual component of the database are supported. Clicking on the Browse button generates a
tabular synopsis of DrugBank's content. This view allows users to casually scroll through the database or re-sort its contents.
 Clicking on a given DrugCard button brings up the full data content for the corresponding drug. A complete explanation of all
the DrugCard fields and sources is given there.
 The PharmaBrowse button allows users to browse through drugs as grouped by their indication. This is particularly useful for
pharmacists and physicians, but also for pharmaceutical researchers looking for potential drug leads.
 The ChemQuery button allows users to draw (using ChemAxon applets) or write (as a SMILES string) a chemical compound
and to search DrugBank for chemicals similar or identical to the query compound.
 The TextQuery button supports a more sophisticated text search (partial word matches, case sensitive, misspellings, etc.) of
the text portion of DrugBank.
 The SeqSearch button allows users to conduct BLAST (protein) sequence searches of the 18,000 sequences contained in
DrugBank. Both single and multiple sequence (i.e. whole proteome) BLAST queries are supported.
 The Data Extractor button opens an easy-to-use relational query search tool that allows users to select or search over various
combinations of subfields. The Data Extractor is the most sophisticated search tool for DrugBank.
Scope and access
Contd…
Screenshot of homepage of DrugBank website
Website: https://go.drugbank.com/
Contd…
PURPLE BOOK DATABASE OF LICENSED BIOLOGICAL
PRODUCTS
The Purple Book is a database that contains information about all FDA-licensed biological products regulated
by the Centre for Drug Evaluation and Research (CDER), including licensed biosimilar and interchangeable
products, and their reference products. The Purple Book also contains information on all FDA-licensed
allergenic, cellular and gene therapy, hematologic, and vaccine products regulated by the Centre for Biologics
Evaluation and Research (CBER).
Some of the information you can find in the Purple Book include:
• The date on which a biological product was licensed under section 351(a) or 351(k) of the Public Health
Service Act (PHS Act).
• Whether a biological product licensed under section 351(k) of the PHS Act has been determined by the FDA
to be biosimilar to or interchangeable with a reference biological product (an already-licensed FDA biological
product).
• The date of expiration of applicable exclusivity, if FDA evaluated the biological product for reference product
exclusivity under section 351(k)(7) of the PHS Act or exclusivity for first interchangeable biological product
under section 351(k)(6) of the PHS Act.
THE ORANGE BOOK
• The Orange Book (officially known as the Approved Drug Products with
Therapeutic Equivalence Evaluations) is a publication that provides
information about drugs approved by the FDA. Specifically, the Orange
Book provides information about drug patent and exclusivity. A drug
patent prohibits other drug companies from marketing or selling a
specific drug for a specific period of time (usually 20 years). Drug
exclusivity, simply put, forbids any other drug companies from selling
generic brands of a specific medication.

More Related Content

What's hot

Pharmacovigilance safety Mon. in clinical trials.pptx
Pharmacovigilance safety Mon. in clinical trials.pptxPharmacovigilance safety Mon. in clinical trials.pptx
Pharmacovigilance safety Mon. in clinical trials.pptxRoshan Yadav
 
Approval and Application Process involved in Investigational New Drug (IND)
Approval and Application Process involved in Investigational New Drug (IND)Approval and Application Process involved in Investigational New Drug (IND)
Approval and Application Process involved in Investigational New Drug (IND)Nipun Gupta
 
pharmacogenomics by vaiibhavi
pharmacogenomics by vaiibhavipharmacogenomics by vaiibhavi
pharmacogenomics by vaiibhavishaikhazaroddin
 
Presentation: Periodic safety update reports
Presentation: Periodic safety update reportsPresentation: Periodic safety update reports
Presentation: Periodic safety update reportsTGA Australia
 
ICH: Introduction, objectives & guidelines: A brief insight.
ICH: Introduction, objectives & guidelines: A brief insight.ICH: Introduction, objectives & guidelines: A brief insight.
ICH: Introduction, objectives & guidelines: A brief insight.RxVichuZ
 
MOLECULAR DOCKING.pptx
MOLECULAR DOCKING.pptxMOLECULAR DOCKING.pptx
MOLECULAR DOCKING.pptxE Poovarasan
 
Structure based drug designing
Structure based drug designingStructure based drug designing
Structure based drug designingSeenam Iftikhar
 
History and progress of pharmacovigilance
History and progress of pharmacovigilanceHistory and progress of pharmacovigilance
History and progress of pharmacovigilanceGagandeep Jaiswal
 
Protocol Understanding_ Clinical Data Management_KatalystHLS
Protocol Understanding_ Clinical Data Management_KatalystHLSProtocol Understanding_ Clinical Data Management_KatalystHLS
Protocol Understanding_ Clinical Data Management_KatalystHLSKatalyst HLS
 
INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
 INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC) INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)Turacoz Skill Development Program
 
1. Unit I - new drug discovery and development.
1. Unit I - new drug discovery and development.1. Unit I - new drug discovery and development.
1. Unit I - new drug discovery and development.Audumbar Mali
 
drug discovery & development
drug discovery & developmentdrug discovery & development
drug discovery & developmentRohit K.
 
Pharmacovigilance Programs of India PvPi
Pharmacovigilance Programs of India PvPiPharmacovigilance Programs of India PvPi
Pharmacovigilance Programs of India PvPiSachinKumar2160
 
INTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptx
INTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptxINTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptx
INTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptxE Poovarasan
 
Investigational New Drug Application
Investigational New Drug ApplicationInvestigational New Drug Application
Investigational New Drug ApplicationSuhas Reddy C
 

What's hot (20)

Pharmacovigilance safety Mon. in clinical trials.pptx
Pharmacovigilance safety Mon. in clinical trials.pptxPharmacovigilance safety Mon. in clinical trials.pptx
Pharmacovigilance safety Mon. in clinical trials.pptx
 
CIOMS (1).pptx
CIOMS (1).pptxCIOMS (1).pptx
CIOMS (1).pptx
 
Molecular docking
Molecular dockingMolecular docking
Molecular docking
 
Approval and Application Process involved in Investigational New Drug (IND)
Approval and Application Process involved in Investigational New Drug (IND)Approval and Application Process involved in Investigational New Drug (IND)
Approval and Application Process involved in Investigational New Drug (IND)
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
 
pharmacogenomics by vaiibhavi
pharmacogenomics by vaiibhavipharmacogenomics by vaiibhavi
pharmacogenomics by vaiibhavi
 
Presentation: Periodic safety update reports
Presentation: Periodic safety update reportsPresentation: Periodic safety update reports
Presentation: Periodic safety update reports
 
ICH: Introduction, objectives & guidelines: A brief insight.
ICH: Introduction, objectives & guidelines: A brief insight.ICH: Introduction, objectives & guidelines: A brief insight.
ICH: Introduction, objectives & guidelines: A brief insight.
 
MOLECULAR DOCKING.pptx
MOLECULAR DOCKING.pptxMOLECULAR DOCKING.pptx
MOLECULAR DOCKING.pptx
 
Structure based drug designing
Structure based drug designingStructure based drug designing
Structure based drug designing
 
History and progress of pharmacovigilance
History and progress of pharmacovigilanceHistory and progress of pharmacovigilance
History and progress of pharmacovigilance
 
Protocol Understanding_ Clinical Data Management_KatalystHLS
Protocol Understanding_ Clinical Data Management_KatalystHLSProtocol Understanding_ Clinical Data Management_KatalystHLS
Protocol Understanding_ Clinical Data Management_KatalystHLS
 
INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
 INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC) INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)
 
PSUR
PSURPSUR
PSUR
 
1. Unit I - new drug discovery and development.
1. Unit I - new drug discovery and development.1. Unit I - new drug discovery and development.
1. Unit I - new drug discovery and development.
 
Pharmaogenomics
PharmaogenomicsPharmaogenomics
Pharmaogenomics
 
drug discovery & development
drug discovery & developmentdrug discovery & development
drug discovery & development
 
Pharmacovigilance Programs of India PvPi
Pharmacovigilance Programs of India PvPiPharmacovigilance Programs of India PvPi
Pharmacovigilance Programs of India PvPi
 
INTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptx
INTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptxINTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptx
INTERNATIONAL NON PROPRIETARY NAMES FOR DRUGS1.pptx
 
Investigational New Drug Application
Investigational New Drug ApplicationInvestigational New Drug Application
Investigational New Drug Application
 

Similar to Mustafa kamal drugs database (assignment 3)

NLM for Health Sciences Student Session 4 – More from the NLM - Not Just PubMed
NLM for Health Sciences Student Session 4  – More from the NLM - Not Just PubMedNLM for Health Sciences Student Session 4  – More from the NLM - Not Just PubMed
NLM for Health Sciences Student Session 4 – More from the NLM - Not Just PubMedmputerba
 
PubChem Database
PubChem DatabasePubChem Database
PubChem DatabaseLucia Ravi
 
Databases pathways of genomics and proteomics
Databases pathways of genomics and proteomics Databases pathways of genomics and proteomics
Databases pathways of genomics and proteomics Sachin Kumar
 
Chemistry Resources Science Teachers
Chemistry Resources Science TeachersChemistry Resources Science Teachers
Chemistry Resources Science TeachersMary Markland
 
Abstract Template
Abstract TemplateAbstract Template
Abstract TemplateIsaac Bruce
 
Talk_linked_data_for_hcls_at_iswc2009
Talk_linked_data_for_hcls_at_iswc2009Talk_linked_data_for_hcls_at_iswc2009
Talk_linked_data_for_hcls_at_iswc2009Jun Zhao
 
No 2 getting started with selecting a database page 1
No 2 getting started with selecting a database page 1No 2 getting started with selecting a database page 1
No 2 getting started with selecting a database page 1Alison Day
 
Abstract template
Abstract templateAbstract template
Abstract templateJessie W
 
Abstract template
Abstract templateAbstract template
Abstract templateuthreddan
 
Exploiting PubChem for Drug Discovery
Exploiting PubChem for Drug DiscoveryExploiting PubChem for Drug Discovery
Exploiting PubChem for Drug DiscoverySunghwan Kim
 
Linked-spls-initial-hcls-presentation-06082012
Linked-spls-initial-hcls-presentation-06082012Linked-spls-initial-hcls-presentation-06082012
Linked-spls-initial-hcls-presentation-06082012Richard Boyce, PhD
 
Explore new Frontiers in Medicine with AI (2).pdf
Explore new Frontiers in Medicine with AI (2).pdfExplore new Frontiers in Medicine with AI (2).pdf
Explore new Frontiers in Medicine with AI (2).pdfNeomatician
 
Explore new Frontiers in Medicine with AI.pdf
Explore new Frontiers in Medicine with AI.pdfExplore new Frontiers in Medicine with AI.pdf
Explore new Frontiers in Medicine with AI.pdfAnne Marie
 
regulatory concepts endfkadflsdjfajfd.ppt
regulatory concepts endfkadflsdjfajfd.pptregulatory concepts endfkadflsdjfajfd.ppt
regulatory concepts endfkadflsdjfajfd.pptomkarborlepwar2002
 

Similar to Mustafa kamal drugs database (assignment 3) (20)

Drug Databases
Drug DatabasesDrug Databases
Drug Databases
 
NLM for Health Sciences Student Session 4 – More from the NLM - Not Just PubMed
NLM for Health Sciences Student Session 4  – More from the NLM - Not Just PubMedNLM for Health Sciences Student Session 4  – More from the NLM - Not Just PubMed
NLM for Health Sciences Student Session 4 – More from the NLM - Not Just PubMed
 
Precompetitive preclinical ADME/tox data and set it free on the web to facili...
Precompetitive preclinical ADME/tox data and set it free on the web to facili...Precompetitive preclinical ADME/tox data and set it free on the web to facili...
Precompetitive preclinical ADME/tox data and set it free on the web to facili...
 
PubChem Database
PubChem DatabasePubChem Database
PubChem Database
 
Pubchem
PubchemPubchem
Pubchem
 
Databases pathways of genomics and proteomics
Databases pathways of genomics and proteomics Databases pathways of genomics and proteomics
Databases pathways of genomics and proteomics
 
Chemistry Resources Science Teachers
Chemistry Resources Science TeachersChemistry Resources Science Teachers
Chemistry Resources Science Teachers
 
Abstract Template
Abstract TemplateAbstract Template
Abstract Template
 
Abstract Template
Abstract TemplateAbstract Template
Abstract Template
 
Talk_linked_data_for_hcls_at_iswc2009
Talk_linked_data_for_hcls_at_iswc2009Talk_linked_data_for_hcls_at_iswc2009
Talk_linked_data_for_hcls_at_iswc2009
 
No 2 getting started with selecting a database page 1
No 2 getting started with selecting a database page 1No 2 getting started with selecting a database page 1
No 2 getting started with selecting a database page 1
 
Abstract template
Abstract templateAbstract template
Abstract template
 
Abstract template
Abstract templateAbstract template
Abstract template
 
Exploiting PubChem for Drug Discovery
Exploiting PubChem for Drug DiscoveryExploiting PubChem for Drug Discovery
Exploiting PubChem for Drug Discovery
 
Online Resources to Support Open Drug Discovery Systems
Online Resources to Support Open Drug Discovery SystemsOnline Resources to Support Open Drug Discovery Systems
Online Resources to Support Open Drug Discovery Systems
 
Linked-spls-initial-hcls-presentation-06082012
Linked-spls-initial-hcls-presentation-06082012Linked-spls-initial-hcls-presentation-06082012
Linked-spls-initial-hcls-presentation-06082012
 
HARSHINI SAIDU
HARSHINI SAIDUHARSHINI SAIDU
HARSHINI SAIDU
 
Explore new Frontiers in Medicine with AI (2).pdf
Explore new Frontiers in Medicine with AI (2).pdfExplore new Frontiers in Medicine with AI (2).pdf
Explore new Frontiers in Medicine with AI (2).pdf
 
Explore new Frontiers in Medicine with AI.pdf
Explore new Frontiers in Medicine with AI.pdfExplore new Frontiers in Medicine with AI.pdf
Explore new Frontiers in Medicine with AI.pdf
 
regulatory concepts endfkadflsdjfajfd.ppt
regulatory concepts endfkadflsdjfajfd.pptregulatory concepts endfkadflsdjfajfd.ppt
regulatory concepts endfkadflsdjfajfd.ppt
 

Recently uploaded

All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...Sérgio Sacani
 
Work, Energy and Power for class 10 ICSE Physics
Work, Energy and Power for class 10 ICSE PhysicsWork, Energy and Power for class 10 ICSE Physics
Work, Energy and Power for class 10 ICSE Physicsvishikhakeshava1
 
Biological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfBiological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfmuntazimhurra
 
Animal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptxAnimal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptxUmerFayaz5
 
Caco-2 cell permeability assay for drug absorption
Caco-2 cell permeability assay for drug absorptionCaco-2 cell permeability assay for drug absorption
Caco-2 cell permeability assay for drug absorptionPriyansha Singh
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real timeSatoshi NAKAHIRA
 
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Sérgio Sacani
 
Artificial Intelligence In Microbiology by Dr. Prince C P
Artificial Intelligence In Microbiology by Dr. Prince C PArtificial Intelligence In Microbiology by Dr. Prince C P
Artificial Intelligence In Microbiology by Dr. Prince C PPRINCE C P
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )aarthirajkumar25
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bSérgio Sacani
 
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisRaman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisDiwakar Mishra
 
GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxAleenaTreesaSaji
 
Formation of low mass protostars and their circumstellar disks
Formation of low mass protostars and their circumstellar disksFormation of low mass protostars and their circumstellar disks
Formation of low mass protostars and their circumstellar disksSérgio Sacani
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Lokesh Kothari
 
Types of different blotting techniques.pptx
Types of different blotting techniques.pptxTypes of different blotting techniques.pptx
Types of different blotting techniques.pptxkhadijarafiq2012
 
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.aasikanpl
 
Presentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxPresentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxgindu3009
 
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡anilsa9823
 

Recently uploaded (20)

All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
 
Work, Energy and Power for class 10 ICSE Physics
Work, Energy and Power for class 10 ICSE PhysicsWork, Energy and Power for class 10 ICSE Physics
Work, Energy and Power for class 10 ICSE Physics
 
Biological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfBiological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdf
 
Animal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptxAnimal Communication- Auditory and Visual.pptx
Animal Communication- Auditory and Visual.pptx
 
Caco-2 cell permeability assay for drug absorption
Caco-2 cell permeability assay for drug absorptionCaco-2 cell permeability assay for drug absorption
Caco-2 cell permeability assay for drug absorption
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real time
 
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
 
Artificial Intelligence In Microbiology by Dr. Prince C P
Artificial Intelligence In Microbiology by Dr. Prince C PArtificial Intelligence In Microbiology by Dr. Prince C P
Artificial Intelligence In Microbiology by Dr. Prince C P
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
 
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisRaman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
 
GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptx
 
Formation of low mass protostars and their circumstellar disks
Formation of low mass protostars and their circumstellar disksFormation of low mass protostars and their circumstellar disks
Formation of low mass protostars and their circumstellar disks
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
 
Engler and Prantl system of classification in plant taxonomy
Engler and Prantl system of classification in plant taxonomyEngler and Prantl system of classification in plant taxonomy
Engler and Prantl system of classification in plant taxonomy
 
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
 
Types of different blotting techniques.pptx
Types of different blotting techniques.pptxTypes of different blotting techniques.pptx
Types of different blotting techniques.pptx
 
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
 
Presentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxPresentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptx
 
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service  🪡
CALL ON ➥8923113531 🔝Call Girls Kesar Bagh Lucknow best Night Fun service 🪡
 

Mustafa kamal drugs database (assignment 3)

  • 1. ASSIGNMENT ON DRUG DATABASE PREPARED BY : MUSTAFA KAMAL AHMED KHAN ENROLMENT NO.: 2018-340-006 B.Sc (Toxicology) - 5TH SEMESTER DEPARTMENT OF TOXICOLOGY JAMIA HAMDARD, NEW DELHI Submitted to- Dr. Nidhi C. Dubey Dated : 26-11-2020
  • 2. DRUG DATABASE Drug databases are sites where information about drugs and medications are stored, and one of the largest (and most commonly used) drug databases is compiled by the Food & Drug Administration (FDA). The FDA is a federal agency that oversees and controls all medications in the U.S., which includes:  Over-the-counter (OTC) medications  Prescription medications  Dietary supplements  Vaccines
  • 3. • The FDA drug database includes most of the drugs they have approved in the U.S. since 1939. Best of all, this database is extremely easy to use. To search this database, you simply need to go to the FDA drug database's website. Once you get to this website, you are able to search the database by typing in the name of the drug or by typing in any active ingredient of a drug. • Additionally, the FDA drug database can be used to search drugs that are currently going through clinical trials and/or the approval process. The FDA must approve a drug before it is legally able to be sold and used in the United States. Therefore, drug companies must formally submit an application to the FDA for the drug to be approved. The drugs that have been submitted to the FDA but not yet approved can be found in this database.
  • 4. Screenshot of homepage of Drugs@FDA Website: https://www.accessdata.fda.gov/scripts/cder/daf/
  • 5. The Pubchem PubChem is a database of chemical molecules and their activities against biological assays. The system is maintained by the National Centre for Biotechnology Information (NCBI), a component of the National Library of Medicine, which is part of the United States National Institutes of Health (NIH). PubChem can be accessed for free through a web user interface. Millions of compound structures and descriptive datasets can be freely downloaded via FTP. PubChem contains substance descriptions and small molecules with fewer than 1000 atoms and 1000 bonds. More than 80 database vendors contribute to the growing PubChem database. Databases PubChem consists of three dynamically growing primary databases. As of 1 November 2017:  Compounds, 93.9 million entries (up from 54 million entries in Sept 2014), contains pure and characterized chemical compounds.  Substances, 236 million entries (up from 163 million entries in Sept 2014), contains also mixtures, extracts, complexes and uncharacterized substances.  Bio-Assay, bioactivity results from 1.25 million (up from 6000 in Sept 2014) high-throughput screening programs with several million values.
  • 6. Searching the databases is possible for a broad range of properties including chemical structure, name fragments, chemical formula, molecular weight, LogP, and hydrogen bond, donor and acceptor count., etc. PubChem contains its own online molecule editor with SMILES/SMARTS and InChI support that allows the import and export of all common chemical file formats to search for structures and fragments. Each hit provides information about synonyms, chemical properties, chemical structure including SMILES and InChI strings, bioactivity, and links to structurally related compounds and other NCBI databases like PubMed. In the text search form the database fields can be searched by adding the field name in square brackets to the search term. A numeric range is represented by two numbers separated by a colon. The search terms and field names are case-insensitive. Parentheses and the logical operators AND, OR, and NOT can be used. AND is assumed if no operator is used. Contd…
  • 7. Website : https://pubchem.ncbi.nlm.nih.gov/ Screenshot of homepage of pubchem website Contd…
  • 8. PubMed is a free search engine accessing primarily the MEDLINE database of references and abstracts on life sciences and biomedical topics. The United States National Library of Medicine (NLM) at the National Institutes of Health maintain the database as part of the Entrez system of information retrieval. From 1971 to 1997, online access to the MEDLINE database had been primarily through institutional facilities, such as university libraries. PubMed, first released in January 1996, ushered in the era of private, free, home- and office-based MEDLINE searching. The PubMed system was offered free to the public starting in June 1997. In addition to MEDLINE, PubMed provides access to:  older references from the print version of Index Medicus, back to 1951 and earlier  references to some journals before they were indexed in Index Medicus and MEDLINE, for instance Science, BMJ, and Annals of Surgery  very recent entries to records for an article before it is indexed with Medical Subject Headings (MeSH) and added to MEDLINE  a collection of books available full-text and other subsets of NLM records  PMC citations  NCBI Bookshelf The Pubmed
  • 9. Website: https://pubmed.ncbi.nlm.nih.gov/ Screenshot of homepage of pubmed website Contd…
  • 10. The DrugBank database is a comprehensive, freely accessible, online database containing information on drugs and drug targets. As both a bioinformatics and a cheminformatics resource, DrugBank combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information. DrugBank has used content from Wikipedia; Wikipedia also often links to Drugbank, posing potential circular reporting issues. The latest release of the database (version 5.0) contains 9591 drug entries including 2037 FDA-approved small molecule drugs, 241 FDA-approved biotech (protein/peptide) drugs, 96 nutraceuticals and over 6000 experimental drugs. Additionally, 4270 non-redundant protein (i.e. drug target/enzyme/transporter/carrier) sequences are linked to these drug entries. Each DrugCard entry contains more than 200 data fields with half of the information being devoted to drug/chemical data and the other half devoted to drug target or protein data. Four additional databases, HMDB, T3DB, SMPDB and FooDB are also part of a general suite of metabolomic/cheminformatic databases. HMDB contains equivalent information on more than 40,000 human metabolites, T3DB contains information on 3100 common toxins and environmental pollutants, SMPDB contains pathway diagrams for nearly 700 human metabolic pathways and disease pathways, while FooDB contains equivalent information on ~28,000 food components and food additives. The DrugBank
  • 11. All data in DrugBank is non-proprietary or is derived from a non-proprietary source. It is freely accessible and available to anyone. In addition, nearly every data item is fully traceable and explicitly referenced to the original source. DrugBank data is available through a public web interface and downloads. Users may query DrugBank in a number of ways:  Simple text queries of the entire textual component of the database are supported. Clicking on the Browse button generates a tabular synopsis of DrugBank's content. This view allows users to casually scroll through the database or re-sort its contents.  Clicking on a given DrugCard button brings up the full data content for the corresponding drug. A complete explanation of all the DrugCard fields and sources is given there.  The PharmaBrowse button allows users to browse through drugs as grouped by their indication. This is particularly useful for pharmacists and physicians, but also for pharmaceutical researchers looking for potential drug leads.  The ChemQuery button allows users to draw (using ChemAxon applets) or write (as a SMILES string) a chemical compound and to search DrugBank for chemicals similar or identical to the query compound.  The TextQuery button supports a more sophisticated text search (partial word matches, case sensitive, misspellings, etc.) of the text portion of DrugBank.  The SeqSearch button allows users to conduct BLAST (protein) sequence searches of the 18,000 sequences contained in DrugBank. Both single and multiple sequence (i.e. whole proteome) BLAST queries are supported.  The Data Extractor button opens an easy-to-use relational query search tool that allows users to select or search over various combinations of subfields. The Data Extractor is the most sophisticated search tool for DrugBank. Scope and access Contd…
  • 12. Screenshot of homepage of DrugBank website Website: https://go.drugbank.com/ Contd…
  • 13. PURPLE BOOK DATABASE OF LICENSED BIOLOGICAL PRODUCTS The Purple Book is a database that contains information about all FDA-licensed biological products regulated by the Centre for Drug Evaluation and Research (CDER), including licensed biosimilar and interchangeable products, and their reference products. The Purple Book also contains information on all FDA-licensed allergenic, cellular and gene therapy, hematologic, and vaccine products regulated by the Centre for Biologics Evaluation and Research (CBER). Some of the information you can find in the Purple Book include: • The date on which a biological product was licensed under section 351(a) or 351(k) of the Public Health Service Act (PHS Act). • Whether a biological product licensed under section 351(k) of the PHS Act has been determined by the FDA to be biosimilar to or interchangeable with a reference biological product (an already-licensed FDA biological product). • The date of expiration of applicable exclusivity, if FDA evaluated the biological product for reference product exclusivity under section 351(k)(7) of the PHS Act or exclusivity for first interchangeable biological product under section 351(k)(6) of the PHS Act.
  • 14. THE ORANGE BOOK • The Orange Book (officially known as the Approved Drug Products with Therapeutic Equivalence Evaluations) is a publication that provides information about drugs approved by the FDA. Specifically, the Orange Book provides information about drug patent and exclusivity. A drug patent prohibits other drug companies from marketing or selling a specific drug for a specific period of time (usually 20 years). Drug exclusivity, simply put, forbids any other drug companies from selling generic brands of a specific medication.